Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites.
Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites.
复制标题
DOI:
10.1158/1055-9965.epi-09-1303
复制
发表时间:
2010-05
期刊:
影响因子:
--
通讯作者:
Jacob P 3rd
中科院分区:
文献类型:
--
作者:
Benowitz NL;Dains KM;Dempsey D;Yu L;Jacob P 3rd
We sought to determine the optimal plasma and urine nicotine metabolites, alone or in combination, to estimate the systemic dose of nicotine after low level exposure. We dosed 36 nonsmokers with 100, 200 or 400 μg deuterium-labeled nicotine (doses similar to exposure to secondhand smoke, SHS) by mouth daily for 5 days and then measured plasma and urine nicotine metabolites at various intervals over 24 hours. The strongest correlations with nicotine dose were seen for the sum of four [cotinine + cotinine-glucuronide + trans-3′-hydroxycotinine + 3HC-glucuronide] or six [ including also nicotine + nicotine-glucuronide] of the major nicotine metabolites in 24 hour urine collection (r = 0.96), with lesser correlations for these metabolites using spot urines corrected for creatinine at various times of day (r = 0.72 – 0.80). Plasma [cotinine + trans 3′ hydroxycotine] was more highly correlated with nicotine dose than plasma cotinine alone (r = 0.82 vs 0.75). Our results provide guidance for selection of biomarkers to estimate the dose of nicotine taken in low level (SHS) tobacco exposure. This is probably relevant to active smoking as well.